Skip to main content
Equibles
CBLL logo

CBLL · Ceribell, Inc. · Metrics

Track CBLL — free

Use CBLL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CBLL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.01 -0.40 (-1.64%)
Russell 2000 member Rebalance outlook locked
Market Cap
$932.20M
Shares
38.38M

CBLL metrics

65 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$24.41
Market cap
$932.20M

Price action

20 metrics
Price change (1W)
-1.1%
Price change (30D)
+26.0%
Price change (3M)
+31.4%
Price change (6M)
+31.9%
Price change (YTD)
+10.9%
Price change (1Y)
+101.6%
Trailing year
Price change (5Y)
—
52-week high
$24.89
52-week low
$10.92
Change from 52-week high
-2.3%
Change from 52-week low
+122.6%
Annualized volatility
52.2%
Annualized volatility (3M)
45.2%
Beta
1.2
RSI (14D)
64.9
Price vs SMA 50
+17.1%
Price vs SMA 200
+22.7%
Avg volume (3M)
388,090
Relative volume
0.8
Average dollar volume
$7.91M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
38.38M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
9.1×
reciprocal yield 10.9%
P / book
7.3
reciprocal yield 13.8%
FCF yield
-5.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
88.9%
Operating margin
-68.6%
Trailing 12 months
Net margin
-64.7%
Gross profit (TTM)
$90.64M
Operating profit (TTM)
−$69.97M
Net income (TTM)
−$66.00M
Trailing 12 months
Diluted EPS (TTM)
$-1.75
FCF margin
-53.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.14

Growth

11 metrics
Revenue growth YoY
+32.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$101.96M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.8%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.4%
Return on assets
-39.7%
Debt / equity
—
Current ratio
9.2
EBITDA (TTM)
−$68.72M
Free cash flow (TTM)
−$54.72M
Quick ratio
8.8
Interest coverage
-38.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$129.26M
Latest balance sheet
Cash & equivalents
$32.66M
Total assets
$166.35M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$54.03M
Capital expenditures (TTM)
$690,000
R&D (TTM)
$22.95M
SG&A (TTM)
—
Stock compensation (TTM)
$16.43M
R&D / revenue
22.5%
Stock compensation / revenue
16.1%

Ownership (13F)

3 metrics
13F filers
122
13F filer change QoQ
0
Institutional ownership
79.5%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$8.91M
Insider-sentiment score
8 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1861107 CUSIP 15678C102 13F (30d) 78 filings 78 filers Visit website Investor relations